- Home
- EBON vs CRIS Comparison
EBON vs CRIS Comparison
Compare EBON & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBON | CRIS |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 20.6M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | EBON | CRIS |
|---|---|---|
| Price | $2.12 | $0.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 2.8K | ★ 221.0K |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $1.61 | $0.44 |
| 52 Week High | $5.90 | $2.80 |
Technical Indicators
Market Signals| Indicator | EBON | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 31.59 |
| Support Level | $1.80 | N/A |
| Resistance Level | $2.33 | $0.57 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 75.00 | 7.66 |
Price Performance
Historical ComparisonAbout EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.